1.
Dupilumab Improves Disease Control and Patient-Reported Outcomes in Adults with Atopic Dermatitis in Clinical Practice: Subgroup Analysis of Black/African American Population from RELIEVE-AD. J of Skin. 2024;8(1):s327. doi:10.25251/skin.8.supp.327